Vose J - Search Results

1

Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration.

Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz AJ, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA. Cheah CY, et al. Among authors: vose j. Am J Hematol. 2016 Sep;91(9):894-9. doi: 10.1002/ajh.24429. Epub 2016 Jun 20. Am J Hematol. 2016. PMID: 27222367 Free article.

2

High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.

Kessinger A, Vose JM, Bierman PJ, Armitage JO. Kessinger A, et al. Among authors: vose jm. Exp Hematol. 1991 Nov;19(10):1013-6. Exp Hematol. 1991. PMID: 1680733

3

Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.

Bashir RM, Bierman PJ, Vose JM, Weisenburger DD, Armitage JO. Bashir RM, et al. Among authors: vose jm. Am J Clin Oncol. 1991 Dec;14(6):478-82. doi: 10.1097/00000421-199112000-00004. Am J Clin Oncol. 1991. PMID: 1720278

4

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT. Armitage JO, et al. Among authors: vose jm. Am J Med. 1991 Dec;91(6):605-11. doi: 10.1016/0002-9343(91)90213-h. Am J Med. 1991. PMID: 1750430

5

The therapy of non-Hodgkin's lymphomas. Introduction and overview.

Vose JM, Bierman PJ, Weisenburger DD, Armitage JO. Vose JM, et al. Hematol Oncol Clin North Am. 1991 Oct;5(5):845-52. Hematol Oncol Clin North Am. 1991. PMID: 1938757 Review.

6

The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO. Vose JM, et al. Ann Oncol. 1991 Feb;2 Suppl 2:171-6. doi: 10.1007/978-1-4899-7305-4_27. Ann Oncol. 1991. PMID: 2049315 Free article. Review.

7

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.

Vose JM, Bierman PJ, Anderson JR, Weisenburger D, Moravec DF, Sorensen S, Hutchins M, Dowling MD, Howe D, Okerbloom J, et al. Vose JM, et al. J Clin Oncol. 1991 Aug;9(8):1421-5. doi: 10.1200/JCO.1991.9.8.1421. J Clin Oncol. 1991. PMID: 2072145

8

Salvage therapy for patients with non-Hodgkin's lymphoma.

Armitage JO, Vose JM, Bierman PJ. Armitage JO, et al. Among authors: vose jm. J Natl Cancer Inst Monogr. 1990;(10):39-43. J Natl Cancer Inst Monogr. 1990. PMID: 2189475 Review.

9

Hodgkin's disease: the role of bone marrow transplantation.

Vose JM, Bierman PJ, Armitage JO. Vose JM, et al. Semin Oncol. 1990 Dec;17(6):749-57. Semin Oncol. 1990. PMID: 2251520 Review.

10

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M, Moravec DF, Howe D, Dowling MD, Mailliard J, et al. Vose JM, et al. J Clin Oncol. 1988 Dec;6(12):1838-44. doi: 10.1200/JCO.1988.6.12.1838. J Clin Oncol. 1988. PMID: 2462026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters